{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T03:31:53Z","timestamp":1782963113003,"version":"3.54.5"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.toxicon.2021.03.012","type":"journal-article","created":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T19:03:00Z","timestamp":1616180580000},"page":"104-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Effects of intravenous administration of recombinant Ph\u03b11\u03b2 toxin in a mouse model of fibromyalgia"],"prefix":"10.1016","volume":"195","author":[{"given":"Mariana Peluci","family":"Garcia Mendes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duana","family":"Carvalho dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rcio J\u00fanior S.","family":"Rezende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana Caroline","family":"Assis Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia Karine","family":"Rigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9lio","family":"Jos\u00e9 de Castro Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus Vinicius","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1973","key":"10.1016\/j.toxicon.2021.03.012_bib1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1126\/science.182.4107.20","article-title":"Depressive disorders: toward a unified hypothesis: clinical, experimental, genetic, biochemical, and neurophysiological data are integrated","volume":"182","author":"Akiskal","year":"1973","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.toxicon.2021.03.012_bib2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1076\/jhin.12.2.207.15535","article-title":"The myth of reserpine-induced depression: role in the historical development of the monoamine hypothesis","volume":"12","author":"Baumeister","year":"2003","journal-title":"J. Hist. Neurosci."},{"key":"10.1016\/j.toxicon.2021.03.012_bib3","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.2042-7158.1969.tb08337.x","article-title":"The analgesic and respiratory depressant activities of N-allyl noretrophine and morphine in the mouse","volume":"21","author":"Bousfield","year":"1969","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.toxicon.2021.03.012_bib4","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4081\/reumatismo.2014.767","article-title":"Pain in fibromyalgia and related conditions","volume":"66","author":"Cassisi","year":"2014","journal-title":"Reumatismo"},{"key":"10.1016\/j.toxicon.2021.03.012_bib5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J. Neurosci. Methods"},{"issue":"No.12","key":"10.1016\/j.toxicon.2021.03.012_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2009.09.006","article-title":"Fibromyalgia: an overview","volume":"122","author":"Clauw","year":"2009","journal-title":"Am. J. Med."},{"key":"10.1016\/j.toxicon.2021.03.012_bib7","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.2014.3266","article-title":"Fibromyalgia: a clinical review","volume":"311","author":"Clauw","year":"2014","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.toxicon.2021.03.012_bib8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10571-012-9871-x","article-title":"An evaluation of the antinociceptive effects of Ph\u03b11\u03b2, a neurotoxin from the spider phoneutria nigriventer, and \u03c9-conotoxin MVIIA, a Cone Snail Conus magus toxin, in rat model of inflammatory and neuropathic pain","volume":"33","author":"de Souza","year":"2013","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.toxicon.2021.03.012_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.toxicon.2014.01.015","article-title":"The effects of Phalpha1beta, a spider toxin, calcium channel blocker, in a mouse fibromyalgia model","volume":"81","author":"de Souza","year":"2014","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2021.03.012_bib10","first-page":"CD012332","article-title":"Oral nonsteroidal anti-inflammatory drugs for fibromyalgia in adults","volume":"3","author":"Derry","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6","key":"10.1016\/j.toxicon.2021.03.012_bib11","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/ar4402","article-title":"Animal models of fibromyalgia","volume":"15","author":"DeSantana","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.toxicon.2021.03.012_bib12","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/j.pain.0000000000000397","article-title":"Analgesic effects of mambalgin peptide inhibitors of acid-sensing ion channels in inflammatory and neuropathic pain","volume":"157","author":"Diochot","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.toxicon.2021.03.012_bib13","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev.pa.20.040180.002301","article-title":"Efficient analysis of experimental observations","volume":"20","author":"Dixon","year":"1980","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.toxicon.2021.03.012_bib14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/syn.10094","article-title":"Preferential action of gabapentin and pregabalin at P\/Q-type voltage-sensitive calcium channels: inhibition of K+-evoked [3H]-norepinephrine release from rat neocortical slices","volume":"45","author":"Dooley","year":"2002","journal-title":"Synapse"},{"key":"10.1016\/j.toxicon.2021.03.012_bib15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00213-003-1707-4","article-title":"Interaction between estrogens and antidepressants in the forced swimming test in rats","volume":"173","author":"Estrada-Camarena","year":"2004","journal-title":"Psychopharmacology"},{"issue":"6","key":"10.1016\/j.toxicon.2021.03.012_bib16","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0031-9384(96)00305-8","article-title":"Chronic mild stress and sucrose consumption: validity as a model of depression","volume":"60","author":"Forbes","year":"1996","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.toxicon.2021.03.012_bib17","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.2174\/138920111798357302","article-title":"The dinamic of TRPA1 Channel: a suitable pharmacological pain target","volume":"12","author":"Garrison","year":"2011","journal-title":"Curr. Pharm. Biothecnol."},{"issue":"2013","key":"10.1016\/j.toxicon.2021.03.012_bib18","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pnpbp.2013.04.009","article-title":"Monoamine neurocircuitry in depression andstrategies for new treatments","volume":"45","author":"Hamon","year":"2013","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.toxicon.2021.03.012_bib19","doi-asserted-by":"crossref","first-page":"15022","DOI":"10.1038\/nrdp.2015.22","volume":"1","author":"H\u00e4user","year":"2015","journal-title":"Fibromyalgia. Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.toxicon.2021.03.012_bib20","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0014-2999(80)90515-4","article-title":"Intrathecal morphine in mice: a new technique","volume":"67","author":"Hylden","year":"1980","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.toxicon.2021.03.012_bib21","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/art.38905","article-title":"The prevalence of fibromyalgia in the general population: a comparison of the American College of Rheumatology 1990, 2010, and modified 2010 classification criteria","volume":"67","author":"Jones","year":"2015","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.toxicon.2021.03.012_bib22","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.bbr.2008.06.008","article-title":"Chronic mild stress generates clear depressive but ambiguous anxiety-like behaviour in rats","volume":"193","author":"Kompagne","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.toxicon.2021.03.012_bib23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.physbeh.2014.03.030","article-title":"Acid-induced hyperalgesia and anxio-depressive comorbidity in rats","volume":"131","author":"Liu","year":"2014","journal-title":"Physiol. Behav."},{"issue":"8","key":"10.1016\/j.toxicon.2021.03.012_bib24","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1523\/JNEUROSCI.14-08-04882.1994","article-title":"Voltage-sensitive calcium channels in spinal nociceptive processing: blockade of N- and P-type channels inhibits formalin-induced nociception","volume":"14","author":"Malmberg","year":"1994","journal-title":"J. Neurosci."},{"key":"10.1016\/j.toxicon.2021.03.012_bib25","first-page":"26","article-title":"Comment on Biogenic amine depletion as a putative animal model","volume":"146","author":"Munro","year":"2010","journal-title":"of fibromyalgia [Pain 2009"},{"key":"10.1016\/j.toxicon.2021.03.012_bib26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pain.2009.05.024","article-title":"Biogenic amine depletion causes chronic muscular pain and tactile allodynia accompanied by depression: a putative animal model of fibromyalgia","volume":"146","author":"Nagakura","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.toxicon.2021.03.012_bib27","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jpsychires.2006.05.008","article-title":"The burden of severe depression: a review of diagnostIc challenges and treatment alternatives","volume":"41","author":"Nemeroff","year":"2007","journal-title":"J. Psychiatr. Res."},{"issue":"No.2","key":"10.1016\/j.toxicon.2021.03.012_bib28","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1254\/jjp.57.243","article-title":"Mechanism of hyperalgesia in SART stressed (repeated cold stress) mice: antinociceptive effect of neurotropin","volume":"57","author":"Ohara","year":"1991","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.toxicon.2021.03.012_bib29","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/2045125312445469","article-title":"The drugs don't work? Antidepressants and the current and future pharmacological management of depression","volume":"2","author":"Penn","year":"2012","journal-title":"Ther Adv Psychopharmacol"},{"key":"10.1016\/j.toxicon.2021.03.012_bib30","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"issue":"2","key":"10.1016\/j.toxicon.2021.03.012_bib31","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/9780470942390.mo110176","article-title":"Depression-related behavioral tests","volume":"2","author":"Powell","year":"2012","journal-title":"Curr Protoc Mouse Biol"},{"key":"10.1016\/j.toxicon.2021.03.012_bib32","doi-asserted-by":"crossref","DOI":"10.1590\/1678-9199-jvatitd-2019-0070","article-title":"Analgesic and side effects of intravenous recombinant Ph\u03b11\u03b2","volume":"26","author":"Rigo","year":"2020","journal-title":"J. Venom. Anim. Toxins Incl. Trop. Dis."},{"key":"10.1016\/j.toxicon.2021.03.012_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2017.05.018","article-title":"The spider toxin Ph\u03b11\u03b2 recombinant possesses strong analgesic activity","volume":"133","author":"Rigo","year":"2017","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2021.03.012_bib34","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/cas.12209","article-title":"Spider peptide Ph\u03b11\u03b2 induces analgesic effect in a model of cancer pain","volume":"104","author":"Rigo","year":"2013","journal-title":"Canc. Sci."},{"key":"10.1016\/j.toxicon.2021.03.012_bib35","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.pharmthera.2010.03.002","article-title":"Pharmacotherapy in fibromyalgia (FM)--implications for the underlying pathophysiology","volume":"127","author":"Schmidt-Wilcke","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.toxicon.2021.03.012_bib36","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fphar.2011.00017","article-title":"Pharmacotherapy for fibromyalgia","volume":"2","author":"Smith","year":"2011","journal-title":"Front. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.toxicon.2021.03.012_bib37","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0304-3959(01)00436-5","article-title":"The novel N-type calcium channel blocker, AM336, produces potent dose-dependent antinociception after intrathecal dosing in rats and inhibits substance P release in rat spinal cord slices","volume":"96","author":"Smith","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.toxicon.2021.03.012_bib38","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.pain.2008.07.014","article-title":"Analgesic effect in rodents of native and recombinant Ph alpha 1 beta toxin, a high-voltage-activated calcium channel blocker isolated from armed spider venom","volume":"140","author":"Souza","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.toxicon.2021.03.012_bib39","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11926-002-0038-5","article-title":"Evidence of involvement of central neural mechanisms in generating fibromyalgia pain","volume":"4","author":"Staud","year":"2002","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.toxicon.2021.03.012_bib40","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/bph.13652","article-title":"The peptide Ph\u03b11\u03b2, from spider venom, acts as a TRPA1 channel antagonist with antinociceptive effects in mice","volume":"174","author":"Tonello","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.toxicon.2021.03.012_bib41","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1124\/jpet.105.087023","article-title":"Inhibition of high voltage-activated calcium channels by spider toxin PnTx3-6","volume":"314","author":"Vieira","year":"2005","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.toxicon.2021.03.012_bib42","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigations of experimental pain in conscious animals","volume":"16","author":"Zimmermann","year":"1983","journal-title":"Pain"}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004101012100091X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004101012100091X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:19:28Z","timestamp":1758575968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004101012100091X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":42,"alternative-id":["S004101012100091X"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2021.03.012","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of intravenous administration of recombinant Ph\u03b11\u03b2 toxin in a mouse model of fibromyalgia","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2021.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}